HIV, once considered a death sentence, has transformed from a life-threatening disease into a manageable chronic condition. This change is due to medical advancements. In the mid-1990s, a person diagnosed with HIV was expected to live just 39 years on average. At that time, the diagnosis was often associated with a grim fate. However, today, thanks to modern treatment, people living with HIV can now live nearly as long as those without the virus. This shows a medical success.
In the past, an HIV diagnosis meant limited treatment options and a drastically shortened life expectancy. But with the introduction of antiretroviral therapy (ART) in the mid-1990s, the outlook for people with HIV changed drastically. ART helps reduce the amount of virus in the body to undetectable levels. As a result, those living with HIV can live long and healthy lives, just like anyone else.
ART is a combination of medicines that work by suppressing the HIV virus, keeping it under control, and preventing it from damaging the immune system. For people who start treatment early and stay on it consistently, the virus becomes undetectable. This means it’s no longer detectable by standard tests. As a result, this scientific breakthrough has allowed HIV to transition from a deadly illness to a treatable disease.
The fight against HIV has been the Undetectable = Untransmittable (U=U) concept. When a person’s viral load drops to undetectable levels through ART, they can no longer transmit HIV to their sexual partners. This has been a life-changer for many individuals who feared passing on the virus to loved ones. In fact, studies have shown that no one with an undetectable viral load has transmitted HIV to a partner through sex. This research has transformed global health strategies and reduced stigma.
The PARTNER and Opposites Attract trials were two major studies on the subject. Both found that individuals who were on effective ART and had undetectable viral loads did not pass the virus to their HIV-negative partners. This discovery has helped to reduce the stigma surrounding HIV. It proves that people with the virus can live normal, healthy lives and have fulfilling relationships.
While ART has revolutionised HIV treatment, millions of people around the world still do not have access to the life-saving treatment. This issue is particularly prominent in low- and middle-income countries, where infrastructure for HIV testing and treatment is still lacking. Therefore, the lack of access to ART in these regions means that many individuals are not able to benefit from the advancements in HIV care. As a result, it leaves them vulnerable to the virus.
Ensuring equal access to healthcare and treatment is a part of addressing the HIV epidemic. Without a commitment to making healthcare accessible to all, the epidemic will continue to disproportionately affect the most vulnerable populations. There is also a need to reduce stigma surrounding HIV and improve healthcare systems worldwide.
Global health leaders, including those from the United Nations and UNAIDS, have set ambitious goals to end the HIV epidemic by 2030. These goals include ensuring that by 2030, 95% of people living with HIV are diagnosed. In addition, 95% are receiving treatment, and 95% achieve undetectable viral loads. These goals aim to end the HIV epidemic by controlling transmission and preventing new infections. They are also trying to provide better care for those already living with the virus.
It’s clear that the science behind HIV treatment is ready and capable of ending the epidemic. However, the path to eradicating HIV will depend on ensuring access to treatment for everyone. Health leaders stress that the system must expand access to ART. Additionally, healthcare systems must strengthen themselves to provide continuous care to all people, regardless of their economic status or location.
